Preventing Maternal and Neonatal Bacterial Infections in Developing Settings With a High Prevalence of HIV: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa; Notice of Intent To Fund Single Eligibility Award, 16290 [05-6257]

Download as PDF 16290 Federal Register / Vol. 70, No. 60 / Wednesday, March 30, 2005 / Notices applications deemed ‘‘Invalid’’ by the Grants.gov Web site Portal will not be transferred to the OPHS eGrants system, and OPHS has no responsibility for any application that is not validated and transferred to OPHS from the Grants.gov Website Portal. Grants.gov will notify the applicant regarding the application validation status. Once the application is successfully validated by the Grants.gov Website Portal, applicants should immediately mail all required hard copy materials to the OPHS Office of Grants Management to be received by the deadlines specified above. It is critical that the applicant clearly identify the Organization name and Grants.gov Application Receipt Number on all hard copy materials. Once the application is validated by Grants.gov, it will be electronically transferred to the OPHS eGrants system for processing. Upon receipt of both the electronic application from the Grants.gov Website Portal, and the required hardcopy mail-in items, applicants will receive notification via mail from the OPHS Office of Grants Management confirming the receipt of the application submitted using the Grants.gov Web site Portal. Applicants are encouraged to initiate electronic applications via the Grants.gov Website Portal early in the application development process, and to submit early on the due date or before. This will aid in addressing any problems with submissions prior to the application deadline. Applicants should contact Grants.gov regarding any questions or concerns regarding the electronic application process conducted through the Grants.gov Website Portal. Mailed or Hand-Delivered Hard Copy Applications Applications submitted in hard copy (via mail or hand-delivered) are required to submit an original and two copies of the application. The original application must be signed by an individual authorized to act for the applicant agency or organization and to assume for the organization the obligations imposed by the terms and conditions of the grant award. Mailed or hand-delivered applications will be considered as meeting the deadline if they are received by the OPHS Office of Grant Management, on or before 5 p.m. Eastern Time on April 4, 2005. The application deadline date requirement specified in this announcement supersedes the instructions in the OPHS–1. Applications that do not meet the deadline will be returned to the applicant unread. VerDate jul<14>2003 15:07 Mar 29, 2005 Jkt 205001 Applications mailed or hand-delivered must be sent to the OPHS Office of Grants Management, 1101 Wootton Parkway, Suite 550, Rockville, Maryland, 20852. For further information contact 301–594–0758. FOR FURTHER INFORMATION CONTACT: OAPP at 301–594–4004 or oapp@osophs.dhhs.gov. research topics and to ensure that all aspects of this agreement can be fulfilled. The Unit has already been a single eligibility recipient of a cooperative agreement for this activity and is midway through completion of this activity. This RFA will allow for completion of the activity. Dated: March 14, 2005. Alma L. Golden, Deputy Assistant Secretary for Population Affairs. [FR Doc. 05–6272 Filed 3–29–05; 8:45 am] Approximately $800,000 is available in FY 2005 to fund this award. It is expected that the award will begin on or before August 31, 2005, and will be made for a 12-month budget period within a project period of up to five years. Funding estimates may change. ADDRESSES: BILLING CODE 4150–30–P C. Funding DEPARTMENT OF HEALTH AND HUMAN SERVICES D. Where To Obtain Additional Information Centers for Disease Control and Prevention For general comments or questions about this announcement, contact: Technical Information Management, CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341–4146, Telephone: 770–488–2700. For program issues, contact: Trudy Messmer, Scientific Review Administrator, 1600 Clifton Road, MS C–19, Atlanta, GA 30333, Telephone: (404) 639–3770, E-mail: TMessmer@cdc.gov. Preventing Maternal and Neonatal Bacterial Infections in Developing Settings With a High Prevalence of HIV: Assessment of the Disease Burden and Evaluation of an Affordable Intervention in Soweto, South Africa; Notice of Intent To Fund Single Eligibility Award A. Purpose The Centers for Disease Control and Prevention (CDC) announces the intent to fund fiscal year (FY) 2005 funds for a cooperative agreement program to conduct a clinical trial to evaluate the efficacy of chlorhexidine vaginal wipes during labor at preventing perinatal and maternal post-partum sepsis in an African setting with a high prevalence of maternal HIV infection. In conjunction with this trial, risk factors for serious neonatal and maternal peripartum infections will be evaluated, with an emphasis on the impact of maternal HIV infection on these outcomes. Prospective maternal and neonatal infections surveillance will also be established to characterize the burden of disease. The Catalog of Federal Domestic Assistance number for this program is 93.283. B. Eligible Applicant Assistance will be provided only to the Respiratory and Meningeal Pathogens Unit of the Medical Research Council of South Africa. No other applications are solicited. The Respiratory and Meningeal Pathogens Unit is the only institution that possesses the requisite scientific and technical expertise, the infrastructure capacity and experience and collaborative relationships necessary to conduct the described PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 Dated: March 24, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 05–6257 Filed 3–29–05; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Development of Influenza Surveillance Network in Vietnam; Notice of Intent To Fund Single Eligibility Award A. Purpose The Centers for Disease Control and Prevention (CDC) announces the intent to fund fiscal year (FY) 2005 funds for a cooperative agreement program to provide support and assistance to the government of Vietnam, specifically the National Institute of Hygiene and Epidemiology for the development and improvement of the influenza surveillance network in Vietnam. This network will focus on the systematic collection of virological and epidemiological information for influenza. The Catalog of Federal Domestic Assistance number for this program is 93.283. E:\FR\FM\30MRN1.SGM 30MRN1

Agencies

[Federal Register Volume 70, Number 60 (Wednesday, March 30, 2005)]
[Notices]
[Page 16290]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Preventing Maternal and Neonatal Bacterial Infections in 
Developing Settings With a High Prevalence of HIV: Assessment of the 
Disease Burden and Evaluation of an Affordable Intervention in Soweto, 
South Africa; Notice of Intent To Fund Single Eligibility Award

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
intent to fund fiscal year (FY) 2005 funds for a cooperative agreement 
program to conduct a clinical trial to evaluate the efficacy of 
chlorhexidine vaginal wipes during labor at preventing perinatal and 
maternal post-partum sepsis in an African setting with a high 
prevalence of maternal HIV infection. In conjunction with this trial, 
risk factors for serious neonatal and maternal peripartum infections 
will be evaluated, with an emphasis on the impact of maternal HIV 
infection on these outcomes. Prospective maternal and neonatal 
infections surveillance will also be established to characterize the 
burden of disease. The Catalog of Federal Domestic Assistance number 
for this program is 93.283.

B. Eligible Applicant

    Assistance will be provided only to the Respiratory and Meningeal 
Pathogens Unit of the Medical Research Council of South Africa. No 
other applications are solicited.
    The Respiratory and Meningeal Pathogens Unit is the only 
institution that possesses the requisite scientific and technical 
expertise, the infrastructure capacity and experience and collaborative 
relationships necessary to conduct the described research topics and to 
ensure that all aspects of this agreement can be fulfilled. The Unit 
has already been a single eligibility recipient of a cooperative 
agreement for this activity and is midway through completion of this 
activity. This RFA will allow for completion of the activity.

C. Funding

    Approximately $800,000 is available in FY 2005 to fund this award. 
It is expected that the award will begin on or before August 31, 2005, 
and will be made for a 12-month budget period within a project period 
of up to five years. Funding estimates may change.

D. Where To Obtain Additional Information

    For general comments or questions about this announcement, contact: 
Technical Information Management, CDC Procurement and Grants Office, 
2920 Brandywine Road, Atlanta, GA 30341-4146, Telephone: 770-488-2700.
    For program issues, contact: Trudy Messmer, Scientific Review 
Administrator, 1600 Clifton Road, MS C-19, Atlanta, GA 30333, 
Telephone: (404) 639-3770, E-mail: TMessmer@cdc.gov.

    Dated: March 24, 2005.
William P. Nichols,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention.
[FR Doc. 05-6257 Filed 3-29-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.